20th Annual Scientific Meeting
We invite you to participate in our next meeting. Please save the date and join us in Brisbane for the 20th AGITG Annual Scientific Meeting from Wednesday 31st October to Friday 2nd November 2018.
2018 Invited Faculty
Professor Brendan Moran Basingstoke and North Hampshire Hospital United Kingdom
Professor Moran has been working at the Hampshire Clinic since 1995 as a Consultant Colorectal Surgeon and General Surgeon. Mr Moran has been a Consultant Surgeon at the Basingstoke and North Hampshire Foundation Trust since 1995 and is now National Lead Clinician for the Low Rectal Cancer National Development Pilot Programme.
Until this latest appointment, he was the Director of the UK Pseudomyxoma Peritonei National Centre, having developed the centre into the largest peritoneal malignancy treatment centre in the world. Other principal appointments include Honorary Senior Clinical Lecturer at the University of Southampton, Cancer Sciences Division, Member of Council of the Association of Coloproctology of Great Britain and Ireland, Lead Surgeon of the National Multidisciplinary Team and the TME Development Programme. Mr Moran undertook his Registrar training in Hampshire and became a Fellow of the Royal College Of Surgeons of Ireland in 1984 and of England in 1997. Particular interests of Mr Moran include, rectal cancers, appendiceal tumours, Pseudomyxoma Peritonei.
Professor Florian Lordick University Cancer Center Leipzig Germany
Professor Lordick is Director and Professor of Oncology of the University Cancer Center Leipzig, Germany.
His scientific focus is clinical and translational research in gastrointestinal cancer, the optimization of multimodal and personalized cancer care, and palliative and supportive care; he has authored and co-authored more than 250 peer-reviewed articles. He is a member of the editorial board of several international journals, including Annals of Oncology, Cancer Treatment Reviews, and Gastric Cancer, and serves as a scientific advisor and reviewer for various medical journals such as The New England Journal of Medicine, The Lancet, The Lancet Oncology, and the European Journal of Cancer.
Dr. Lordick is on the board of directors and serves as secretary of the German Cancer Society (DKG), for which he is also chairman of the palliative care working group. He is a member of the European Society for Medical Oncology (ESMO), the European Organization of Research and Treatment of Cancer (EORTC), and the American Society of Clinical Oncology (ASCO), among other professional organizations. He is the president elect of the International Gastric Cancer Association and has been nominated to the European School of Oncology (ESO) core faculty.
Dr. Lordick received his medical training at the Universities of Regensburg, Munich, and Lausanne. He completed his residency in internal medicine and oncology/hematology at the Technical University of Munich.
Professor Aldo Scarpa University of Verona Italy
Professor Scarpa is the Director of the ARC-Net Research Centre for Applied Research on Cancer and Chair of the Department of Pathology at the University and Hospital Trust of Verona.
Prof. Scarpa received his MD from the University of Padua and his PhD in Human Oncology and Molecular Pathology from the University of Verona. He trained in Japan at the National Cancer Center of Tokyo, at the New York University and La Jolla Cancer Research Center, USA, and at the Nürnberg Universität, Germany.
He leads the Cancer Biobank Network Programme in the Veneto Region (Italy) (population 4,900,000), and is Chief of the Diagnostic Molecular Pathology Laboratory, officially recognised by the Veneto Government as one of two referral centres for cancer molecular diagnostics in the region and leader of the Italian effort in the International Cancer Genome Consortium funded by the Italian Ministry of Research and Ministry of Health. He is also a Principle Investigator of the Italian National Consortium for early diagnostics in cancer funded by the Italian Association for Cancer research (AIRC).
The research focus of Prof Scarpa is the translation into clinical practice of molecular subclassifications of cancers with prognostic-diagnostic-therapeutic relevance. He has published over 330 papers cited in PubMed. His current efforts are devoted to the prospective clinical validation of liquid biopsies using matched molecular characterisation of primary tumours and sequential plasma samples from patients under treatment.
Professor Diana Sarfati University of Otago Wellington New Zealand
Professor Sarfati is a public health physician and epidemiologist with a particular interest in the interface between public health and clinical medicine. She is co-Head of the Department of Public Health and the Director of the Cancer and Chronic Conditions (C3) research group.
Professor Sarfati has a range of research interests relating to cancer, long term conditions and health services. She has led a large body of work relating to ethnic disparities in cancer outcomes. This work has resulted in the identification of key patient and health system factors that influence cancer survival. This work has been used extensively by health policy makers, clinicians and other researchers to develop policies and practices that aim to reduce inequities in cancer outcomes.
Her work in screening has included both research and policy elements. She is a member of the National Screening Advisory Group, and past member of the Bowel Cancer Screening Taskforce, and the National Bowel Cancer Working Group. She has written many academic papers relating to screening and is currently leading work on the benefits and harms of rheumatic heart disease screening. Multimorbidity is the co-existence of long-term medical conditions. Multimorbidity is common, particularly among those aged over 65 years, Māori and Pacific people and those living in socioeconomic deprivation. Professor Sarfati has a strong interest in research focused on multimorbidity in general, and in the context of cancer specifically. Her research focuses on the role of health services in improving outcomes for people with a range of health-related conditions.
Professor Sarfati is a past member of the National Ethics Advisory Committee which advises the Minister of Health on health-related ethical issues of national significance, the Board of the Cancer Society (Wellington Division), the Cancer Society Medical and Scientific Assessment Committee (Wellington) and the National Cancer Society Health Promotion Committee.
The Australasian Gastro-Intestinal Trials Group (AGITG) is the only research organisation in the Australasian region with a focus on gastro-intestinal cancers.
The AGITG Annual Scientific Meeting is widely known throughout Australasia as the premier meeting in the gastro-intestinal (GI) cancer space. The three day meeting provides gastro-intestinal cancer clinicians, researchers and allied health specialists with the opportunity to present their research and discuss current challenges and innovations, as well as to hear from international and local leaders on the latest in research and treatments. The exchange of knowledge and expertise is strongly encouraged in our friendly and collegiate meeting environment. The meeting also provides an opportunity for involvement of health professionals in the scientific activities of the AGITG.
The program structure consists of three days of dedicated program which include keynote sessions featuring international guest speakers, plenary and symposia sessions, trials presentations, poster session, new concepts symposium and workshops.
The Executive Organising Committee is working to present a dynamic program of interest to all involved in the care of patients with gastro-intestinal cancer.
We look forward to seeing you in Brisbane!
Prof Eva Segelov
AGITG Annual Scientific Meeting Convenor
Mr Russell Conley
AGITG Chief Executive Officer
ASM Invited Faculty 1999 – 2017
- Prof John Bridgewater, University College London Hospitals, UK
- A/Prof Thierry Alcindor, McGill University / Canadian Cancer Trials Group, Canada
- Dr Ian Chau, The Royal Marsden Hospital, UK
- Prof Karyn Goodman, University of Colorado, USA
- Prof John V. Reynolds, St. James’s Hospital and Trinity College, Ireland
- Prof Edgar Ben-Josef, University of Pennsylvania, USA
- Dr Rebecca Wong, Princess Margaret Cancer Centre / Canadian Cancer Trials Group, Canada
- Dr Jeffrey Meyerhardt, Dana-Farber Cancer Institute, USA
- Prof Phil Quirke, University of Leeds, UK
- Prof Alan Venook , UCSF, Helen Diller Family Comprehensive Cancer Center, USA
- A/Prof Magnus Nilsson, The Karolinska Institute , Sweden
- Dr Simron Singh, Sunnybrook Odette Cancer Centre, Canada
- Prof Bruce Minsky, University of Texas MD Anderson Cancer Center, USA
- Dr James Fleshman, Baylor University Medical Center, USA
- Dr Johanna Bendell, Sarah Cannon Research Institute, Nashville, USA
- Dr Alberto Bardelli, University of Torino, Italy
- Dr Scott Kopetz , University of Texas MD Anderson Cancer Center, USA
- Prof Tim Maughan, University of Oxford, UK
- Dr Hagen Kennecke, British Columbia Cancer Agency, Canada
- Prof Jordan Berlin, Vanderbilt University, USA
- Dr Maarten Hulshof, Academic Medical Centre, Amsterdam
- Dr David Ilson, Memorial Sloan Kettering Cancer Centre Memorial Hospital, USA
- Dr Robert Kerbel, Sunnybrook Health Sciences Centre, Canada
- Prof Christophe Mariette, University Hospital C. Huriez, France
- Dr Matthew Seymour, Cancer Research UK University of Leeds, UK
- Prof Yoon-Koo Kang, Asan Cancer Centre, South Korea
- Prof Rob Glynne-Jones, Mt Vernon Cancer Centre, UK
- Prof David Kerr, University of Oxford, UK
- Dr Stanley Hamilton, M.D. Anderson Cancer Centre, USA
- Dr Fotios Loupakis, University of Pisa, Italy
- Dr Richard Goldberg, The Ohio State University Comprehensive Cancer Centre
- Prof Ashley Grossman, University of Oxford, UK
2012 – Sydney
- Prof Charles Blanke, BC Cancer Agency, Canada
- Prof Juan Valle, University of Manchester, UK
- Dr Murray Brennan, Memorial Sloan-Kettering Cancer Center, New York, USA
- Prof Karin Haustermans, Leuven Cancer Institute, Leuven, Belgium
- Prof Fortunato Ciardiello, Seconda Universita di Napoli, Italy
- A/Prof Herb Hurwitz, Duke University, USA
- Prof Derek Alderson – University of Birmingham, UK
- Prof Arthur William Blackstock – Wake Forest University Baptist Medical Center, USA
- Dr Andres Cervantes, University of Valencia, Spain
- Dr Heikki Joensuu, University of Helsinki, Finland
- Prof Josep Tabernero, Vall d’Hebron Institute of Oncology, Spain
- Dr Harpreet Wasan, Hammersmith Hospital, Imperial College, London, UK
- Dr Lisa Kachnic – Boston University Medical Centre, USA
- Prof John Primrose – University of South Hampton, UK
- Prof Jim Cassidy – University of Glasgow, UK
- Prof David Cunningham – Royal Marsden Hospital, UK
- Prof Hans Schmoll – Martin-Luther-University, Germany (via link)\
- Dr Gary Middleton – Royal Surrey County Hospital, UK
- Prof Daniel Haller – University of Pennsylvania, USA
- Dr Leonard Gunderson – Mayo Clinic, USA
- Dr Nabil Rizk – Memorial Sloan-Kettering Cancer Center, USA
- Dr Al Benson – Robert H. Lurie Comprehensive Cancer Center of Northwestern University, USA
- Prof Karin Haustermans – Radiation Oncology Department, University Hospital Gasthuisberg, Belgium
- Prof Robin McLeod – Division of Surgery, Mount Sinai Hospital, Ontario, Canada
- Prof Charles Blanke – British Columbia Cancer Agency, Vancouver, Canada
- Assoc Prof Pierce Chow – Duke-NUS Graduate Medical School, Singapore
- Prof Howard Hochster – Director, GI Oncology, NYU Cancer Institute, USA
- Prof Andrew Kennedy – Wake Radiology Oncology, North Carolina, USA
- Prof Kjell Öberg – Medical Faculty of Uppsala University, Sweden
- Dr Josep Tabernero – Vall d’Hebron University Hospital, Barcelona, Spain
- Prof Bob Benjamin – medical oncologist, MD Anderson Cancer Centre, USA
- Prof David Cunningham – medical oncologist, Royal Marsden Hospital, UK
- Dr Jonathan Fletcher, Cytogeneticist and Associate in Medicine and Pathology at the Children’s Hospital, Staff Medical and Pediatric Oncologist at Dana-Farber Cancer Institute and Clinical Associate in Pathology, Massachusetts General Hospital, & Brigham and Women’s Hospital, USA
- Assoc Prof Laura Dawson – radiation oncologist, University of Toronto, Canada
- Prof Nick Lemoine – Cancer Research UK Clinical Centre, UK
- Prof Bernard Nordlinger, Ambroise Paré Hospital, France
- Dr Bruno Sangro – Director of the Liver Unit at Clinica Universitaria, and Associate Professor of Medicine at the University of Navarra School of Medicine, Pamplona, Spain
- Dr Richie Soong – Assistant Professor in the Dept of Pathology, National University of Singapore
- Dr Christophe Tournigand – St Anthony University Hospital, France
- Dr Louis M. Weiner – Chairman of the Department of Medical Oncology, Fox Chase Cancer Centre, USA
- Prof Bruce Minsky – Vice Chair, Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, USA
- Dr Takeshi Sano – Head of the Gastric Surgery Division, National Cancer Center Hospital, Tokyo
- Dr Marc Peeters is Coordinator of the Digestive Oncology Unit, University Hospital, Ghent, Flanders, Belgium
- Dr Gunnar Folprecht – Head of the Outpatient Unit for Medical Oncology, University Hospital, Fetscherstr, Dresden, Germany
- Dr Rob Glynne-Jones – Lead Clinician in Colorectal Cancer/Gastrointestinal Cancer, Mount Vernon Cancer Centre, Middlesex, UK
- Dr Norman Wolmark – Department of Human Oncology, Drexel University School of Medicine, Philadelphia, USA
- Doctor Graeme Poston – consultant hepato-biliary surgeon, Royal Liverpool University Hospital, Liverpool, UK
- Prof David Kerr – Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology at the University of Oxford, UK
- Associate Professor Jordan Berlin – medical oncologist and Director, Clinical Gastro-intestinal Program at the Vanderbilt Medical Centre, Tennessee, USA
- Prof Claus-Henning Kohne is Director of the Hospital for Oncology and Haematology, Oldenburg, Germany
- Professor Christopher Willett – Chairman of the Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA
- Dr Axel Grothey – medical oncologist, Mayo Clinic, USA
- Prof James Garden – Regius Professor of Clinical Surgery, Director of the Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh and Head of the School of Clinical Sciences and Community Health at the University of Edinburgh, UK
- Prof Ren Adam – Hospital Paul Brousse, Villejuif & Professor of Surgery at the Faculty of Medicine, Paris-Sud University, France
- Prof Hans-Joachim Schmoll, University of Halle, Germany
- Prof Michael Heinrich – medical oncologist
- Professor Eric Van Cutsem – University of Leuwen, Belgium
- Dr David Ilson – Associate Attending Physician, Gastro-intestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, USA
- Dr Pierce Chow – Hepato-pancreato-biliary / General Surgeon, Singapore General Hospital, Singapore
- Prof John Northover – Director of The Colorectal Cancer Unit, Cancer Research, St Mark’s Hospital for Intestinal and Colorectal Disorders and Professor of Intestinal Surgery, Faculty of Medicine, Imperial College, UK
- Dr Adrian Crellin – Radiation Oncologist and Clinical Director of Oncology, United Leeds Teaching Hospital and Member of the MRC Upper GI Cancer Working Group, UK
- Dr Dan Haller – medical oncologist, University of Pennsylvania, USA
- Professor Aimery de Gramont – Hopital Saint-Antoine, Paris, France
- Dr Shinn Yeung – Clinical Research Fellow in Hepato-Biliary Surgery, Basingstoke, UK
- Dr Takeshi Sano – surgeon, National Cancer Center Hospital, Tokyo, Japan
- Dr Markus Buechler – surgeon, University of Bern, Switzerland
- Dr Steven Curley – surgeon, MD Anderson Cancer Center, USA
- Dr James Church – surgeon, Cleveland Clinic, USA
- Dr Chris Crane – radiation oncologist, MD Anderson Cancer Center, Houston, USA
- Prof Robert Madoff – Professor of Surgery, University of Minnesota, USA
- Prof Bernard Nordlinger – Professor of Surgical Oncology, Ambroise Pare Hospital, France
- Prof John Neoptolemos – Professor of Surgery, University of Liverpool, UK
- Prof Jan Leer – Professor of Radiation Oncology, University of Nijmegen, Netherlands
- Dr Nancy Kemeny – medical oncologist, Memorial Sloan Kettering Cancer Centre, USA
- Dr Kevin Conlon – upper gastro-intestinal surgeon, Memorial-Sloan Kettering Cancer Centre, USA
- Dr Jeffery Milsom – Chief of Colorectal Surgery, Mount Sinai Medical Centre, USA